Delivery Order SPE2DB22D3009-SPE2DB25FAQ39

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $9,517.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,558,422,780 units of 4 mg Naloxone HCl Nasal Spray, a critical medication used to treat opioid overdoses. The contract is a Firm Fixed Price Delivery Order with a completion date of September 13, 2022. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,315.16 Firm Fixed Price delivery order is for the supply of 4,566,400 units of 4 mg Naloxone HCl nasal spray. The contract has an ultimate completion date of November 13, 2024 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,394.84 firm fixed-price delivery order is for the procurement of 4,567,059,630 units of Naloxone HCL 4 mg Nasal Spray, with a completion date of January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,367,200 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,950.71 and an ultimate completion date of August 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,247.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559130445 - Naloxone HCL 4 mg Nasal Spray, with an ultimate completion date of November 18, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,780.87 Firm Fixed Price Delivery Order is for the supply of 4,562,158,402 units of Naloxone HCl 4 mg Nasal Spray. The award has an ultimate completion date of September 14, 2023 and was made on September 13, 2023. There was no set-aside designation for this contract. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation. The $12,631.36 firm fixed-price delivery order is for the supply of 4,565,456,344 units of Naloxone HCl 4 mg Nasal Spray, with a completion date of August 15, 2024. As a leading pharmaceutical distributor, Amerisourcebergen has been awarded numerous contracts by various defense and civilian agencies to provide a wide range of essential medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,121.34 firm fixed-price delivery order is for the supply of 4,563,541,399 units of 4 mg Naloxone HCl nasal spray, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., maintains a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order contract with a ceiling value of $1,875.42 to provide 4 mg naloxone hydrochloride nasal spray. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award, with a ceiling value of $1,818.22, was issued to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,564,766,814 units of naloxone hydrochloride 4 mg nasal spray in 2-pack cartons, with a completion date of June 3, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAQ39
    Delivery Order

This federal contract award, valued at $1,463.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a delivery order ID of SPE2DB22D3009|SPE2DB25FAQ39, is for the supply of 4,567,139,965 units of Naloxone HCl 4 mg Nasal Spray. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 4, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/5/25, 9:49 AM